RETRACTED: Low-expressed GAS5 injure myocardial cells and progression of chronic heart failure via regulation of miR-223-3P
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. After a thorough investigation, the Editor has concluded that the accept...
Saved in:
Published in | Experimental and molecular pathology Vol. 117; p. 104529 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Inc
01.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
This article has been retracted at the request of the Editor-in-Chief.
After a thorough investigation, the Editor has concluded that the acceptance of this article was partly based upon the positive advice of one illegitimate reviewer report. The report was submitted from an email account which was provided to the journal as a suggested reviewer during the submission of the article. Although purportedly a real reviewer account, the Editor has concluded that this was not of an appropriate, independent reviewer.
This manipulation of the peer-review process represents a clear violation of the fundamentals of peer review, our publishing policies, and publishing ethics standards. Apologies are offered to the reviewer whose identity was assumed and to the readers of the journal that this deception was not detected during the submission process. |
---|---|
AbstractList | This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).
This article has been retracted at the request of the Editor-in-Chief.
After a thorough investigation, the Editor has concluded that the acceptance of this article was partly based upon the positive advice of one illegitimate reviewer report. The report was submitted from an email account which was provided to the journal as a suggested reviewer during the submission of the article. Although purportedly a real reviewer account, the Editor has concluded that this was not of an appropriate, independent reviewer.
This manipulation of the peer-review process represents a clear violation of the fundamentals of peer review, our publishing policies, and publishing ethics standards. Apologies are offered to the reviewer whose identity was assumed and to the readers of the journal that this deception was not detected during the submission process. Chronic heart failure (CHF) is a common disease in clinical practice, and its incidence has been increasing in recent years. Understanding the pathogenesis of CHF is the key to its future clinical diagnosis and treatment. Molecular research is a hot topic in modern hospitals, and long non-coding RNA (LncRNA) has been gradually understood and applied in many diseases. The situation of LncRNA GAS5 in CHF is still unclear, so this experiment will investigate the situation of GAS5 in CHF and its effect on myocardial cells, aiming to gain a preliminary understanding of the mechanism of GAS5's effect on CHF. In this study, the expression of GAS5 and miR-223-3p in peripheral blood of CHF patients and healthy subjects was first detected, GAS5 was low in CHF while miR-223-3p was high (P < 0.05). Subsequently, ROC curve analysis showed that GAS5 and miR-223-3p had good predictive value for the occurrence and recurrence of CHF. Secondly, through in vitro experiments, we found that inhibition of GAS5 with elevated expression of miR-223-3p decreased the proliferative capacity of cardiomyocytes and increased apoptotic capacity and inflammatory factors (P < 0.050). Through dual luciferase reporter and RNA immunoprecipitation experiment, we found that miR-223-3p was regulated by GAS5 in a targeted manner. Chronic heart failure (CHF) is a common disease in clinical practice, and its incidence has been increasing in recent years. Understanding the pathogenesis of CHF is the key to its future clinical diagnosis and treatment. Molecular research is a hot topic in modern hospitals, and long non-coding RNA (LncRNA) has been gradually understood and applied in many diseases. The situation of LncRNA GAS5 in CHF is still unclear, so this experiment will investigate the situation of GAS5 in CHF and its effect on myocardial cells, aiming to gain a preliminary understanding of the mechanism of GAS5's effect on CHF. In this study, the expression of GAS5 and miR-223-3p in peripheral blood of CHF patients and healthy subjects was first detected, GAS5 was low in CHF while miR-223-3p was high (P < 0.05). Subsequently, ROC curve analysis showed that GAS5 and miR-223-3p had good predictive value for the occurrence and recurrence of CHF. Secondly, through in vitro experiments, we found that inhibition of GAS5 with elevated expression of miR-223-3p decreased the proliferative capacity of cardiomyocytes and increased apoptotic capacity and inflammatory factors (P < 0.050). Through dual luciferase reporter and RNA immunoprecipitation experiment, we found that miR-223-3p was regulated by GAS5 in a targeted manner.Chronic heart failure (CHF) is a common disease in clinical practice, and its incidence has been increasing in recent years. Understanding the pathogenesis of CHF is the key to its future clinical diagnosis and treatment. Molecular research is a hot topic in modern hospitals, and long non-coding RNA (LncRNA) has been gradually understood and applied in many diseases. The situation of LncRNA GAS5 in CHF is still unclear, so this experiment will investigate the situation of GAS5 in CHF and its effect on myocardial cells, aiming to gain a preliminary understanding of the mechanism of GAS5's effect on CHF. In this study, the expression of GAS5 and miR-223-3p in peripheral blood of CHF patients and healthy subjects was first detected, GAS5 was low in CHF while miR-223-3p was high (P < 0.05). Subsequently, ROC curve analysis showed that GAS5 and miR-223-3p had good predictive value for the occurrence and recurrence of CHF. Secondly, through in vitro experiments, we found that inhibition of GAS5 with elevated expression of miR-223-3p decreased the proliferative capacity of cardiomyocytes and increased apoptotic capacity and inflammatory factors (P < 0.050). Through dual luciferase reporter and RNA immunoprecipitation experiment, we found that miR-223-3p was regulated by GAS5 in a targeted manner. |
ArticleNumber | 104529 |
Author | Li, Bo Li, Gang Qiang, Xu Du, Pang Jin, Dayong Liu, Haochen Guo, Jianjun |
Author_xml | – sequence: 1 givenname: Gang surname: Li fullname: Li, Gang organization: Department of Cardiovascular Surgery, Xian Children's Hospital, No. 69 Xijuyuan Land, Xian, 710003, Shannxi Province, China – sequence: 2 givenname: Pang surname: Du fullname: Du, Pang organization: Department of Radiology, Tangdu Hospital, Xian, 710003, Shannxi, China – sequence: 3 givenname: Xu surname: Qiang fullname: Qiang, Xu organization: Department of Cardiovascular Surgery, Xian Children's Hospital, No. 69 Xijuyuan Land, Xian, 710003, Shannxi Province, China – sequence: 4 givenname: Dayong surname: Jin fullname: Jin, Dayong organization: Department of Radiology, Tangdu Hospital, Xian, 710003, Shannxi, China – sequence: 5 givenname: Haochen surname: Liu fullname: Liu, Haochen organization: Department of Cardiovascular Surgery, Xian Children's Hospital, No. 69 Xijuyuan Land, Xian, 710003, Shannxi Province, China – sequence: 6 givenname: Bo surname: Li fullname: Li, Bo organization: Department of Cardiovasology, Tangdu Hospital, Xian, 710003, Shannxi, China – sequence: 7 givenname: Jianjun surname: Guo fullname: Guo, Jianjun email: jianjunguo452@163.com organization: Department of Cardiovascular Surgery, Xian Children's Hospital, No. 69 Xijuyuan Land, Xian, 710003, Shannxi Province, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32926880$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUFP2zAYhq0JNArbL5g0-bhLymfHCcmkHarSAVKlTV13thz7C7hK4s5OCtX-PA4tFw6cLNnP88nf-56Tk851SMgXBlMGLL_cTPf41G6nHPh4IzJefiATBmWeQCmyEzIBYCIRBcAZOQ9hAwAlMP6RnKW85HlRwIT8Xy3Wq9l8vbj-TpfuMcGnrccQ0NCb2Z-M2m4zeKTt3mnljVUN1dg0garO0K139yNrXUddTfWDd53V9AGV72mtbDOaO6uox_uhUf2Ra-0q4TxN0t-fyGmtmoCfj-cF-ftzsZ7fJstfN3fz2TLRHAQkeJUhCFMwUam01GhUloPWtTYsi285MqErAYYXdVHpqshNyaC6MkxhqnNu0gvy7TA3_vjfgKGXrQ3jHqpDNwTJheBFjI9lEf16RIeqRSO33rbK7-VrYBEoD4D2LgSPtdS2f9mt93FlyUCO5ciNfClHjuXIQznRTd-4r-Pft34cLIwR7Sx6GbTFLuZgPepeGmff9Z8BPxypPQ |
CitedBy_id | crossref_primary_10_3389_fcvm_2021_747449 crossref_primary_10_1080_21655979_2021_2002498 crossref_primary_10_1007_s12033_022_00471_7 crossref_primary_10_1038_s41598_024_58239_9 crossref_primary_10_3390_antiox10050745 crossref_primary_10_3892_etm_2021_10796 crossref_primary_10_1007_s13273_021_00147_4 crossref_primary_10_1161_JAHA_121_021129 crossref_primary_10_2217_bmm_2022_0697 crossref_primary_10_3892_mmr_2022_12735 |
Cites_doi | 10.1002/ejhf.1146 10.1002/ejhf.839 10.1007/s12350-015-0336-8 10.1002/ejhf.669 10.1016/j.ccell.2018.03.006 10.1016/j.canlet.2018.06.039 10.1007/s12035-016-0246-z 10.1093/eurheartj/ehx460 10.1016/j.bbi.2018.02.013 10.14715/cmb/2017.63.4.1 10.3892/mmr.2017.7653 10.15420/cfr.2016:25:2 10.3389/fphar.2017.00464 10.1177/2048872617748553 10.1016/j.tox.2017.05.007 10.1002/jcb.28789 10.18632/oncotarget.19197 10.1161/CIRCULATIONAHA.116.025941 10.1016/S0140-6736(17)32520-5 10.1161/HYPERTENSIONAHA.116.07259 |
ContentType | Journal Article |
Copyright | 2020 Elsevier Inc. Copyright © 2020 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2020 Elsevier Inc. – notice: Copyright © 2020 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.yexmp.2020.104529 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1096-0945 |
ExternalDocumentID | 32926880 10_1016_j_yexmp_2020_104529 S0014480020308054 |
Genre | Retracted Publication Journal Article |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29G 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABFRF ABGSF ABJNI ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DOVZS DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HDY HLW HMK HMO HVGLF HZ~ IHE J1W K-O KOM L7B LCYCR LG5 LX2 M29 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SBG SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K UHS UNMZH WUQ X7M XPP ZGI ZMT ZU3 ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACIEU ACRPL ACVFH ADCNI ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION CGR CUY CVF ECM EIF NPM 7X8 EFKBS |
ID | FETCH-LOGICAL-c2040-e75e04d814ba39ceda560ccfcd15e756e14cb40d28f8bcb86d910b7d1ae3c62d3 |
IEDL.DBID | .~1 |
ISSN | 0014-4800 1096-0945 |
IngestDate | Wed Aug 20 04:01:42 EDT 2025 Thu Apr 03 07:07:55 EDT 2025 Tue Jul 01 01:56:50 EDT 2025 Thu Apr 24 23:00:52 EDT 2025 Fri Feb 23 02:43:14 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Chronic heart failure Diagnosis miR-223-3p GAS5 Myocardial cells |
Language | English |
License | Copyright © 2020 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2040-e75e04d814ba39ceda560ccfcd15e756e14cb40d28f8bcb86d910b7d1ae3c62d3 |
Notes | retraction ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Correction/Retraction-3 |
PMID | 32926880 |
PQID | 2442845215 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2442845215 pubmed_primary_32926880 crossref_citationtrail_10_1016_j_yexmp_2020_104529 crossref_primary_10_1016_j_yexmp_2020_104529 elsevier_sciencedirect_doi_10_1016_j_yexmp_2020_104529 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2020 2020-12-00 20201201 |
PublicationDateYYYYMMDD | 2020-12-01 |
PublicationDate_xml | – month: 12 year: 2020 text: December 2020 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Experimental and molecular pathology |
PublicationTitleAlternate | Exp Mol Pathol |
PublicationYear | 2020 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Chen (10.1016/j.yexmp.2020.104529_bb0025) 2018; 11 Christiansen (10.1016/j.yexmp.2020.104529_bb0030) 2017; 135 Conrad (10.1016/j.yexmp.2020.104529_bb0035) 2018; 391 Chen (10.1016/j.yexmp.2020.104529_bb0020) 2017; 12 Buakhamsri (10.1016/j.yexmp.2020.104529_bb0015) 2019; 102 Zhang (10.1016/j.yexmp.2020.104529_bb0135) 2019; 12 Wu (10.1016/j.yexmp.2020.104529_bb0130) 2017; 54 Del Giudice (10.1016/j.yexmp.2020.104529_bb0045) 2018; 70 Dewaele (10.1016/j.yexmp.2020.104529_bb0050) 2017 Meijers (10.1016/j.yexmp.2020.104529_bb0085) 2017; 19 Travin (10.1016/j.yexmp.2020.104529_bb0115) 2017; 24 Tao (10.1016/j.yexmp.2020.104529_bb0110) 2017; 386 Liu (10.1016/j.yexmp.2020.104529_bb0070) 2017; 16 Wang (10.1016/j.yexmp.2020.104529_bb0120) 2016; 68 Aldahl (10.1016/j.yexmp.2020.104529_bb0005) 2017; 38 Gu (10.1016/j.yexmp.2020.104529_bb0055) 2018; 434 Mair (10.1016/j.yexmp.2020.104529_bb0080) 2018; 7 Cosmi (10.1016/j.yexmp.2020.104529_bb0040) 2018; 20 Roffel (10.1016/j.yexmp.2020.104529_bb0100) 2019 Hao (10.1016/j.yexmp.2020.104529_bb0060) 2017; 8 Liu (10.1016/j.yexmp.2020.104529_bb0075) 2019; 120 Savarese (10.1016/j.yexmp.2020.104529_bb0105) 2017; 3 Platz (10.1016/j.yexmp.2020.104529_bb0095) 2017; 19 Wang (10.1016/j.yexmp.2020.104529_bb0125) 2018; 33 Bao (10.1016/j.yexmp.2020.104529_bb0010) 2017; 63 Zhou (10.1016/j.yexmp.2020.104529_bb0140) 2017; 8 34602257 - Exp Mol Pathol. 2021 Oct;122:104683 |
References_xml | – volume: 20 start-page: 888 issue: 5 year: 2018 ident: 10.1016/j.yexmp.2020.104529_bb0040 article-title: Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes[J] publication-title: Eur. J. Heart Fail. doi: 10.1002/ejhf.1146 – volume: 19 start-page: 1154 issue: 9 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0095 article-title: Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review[J] publication-title: Eur. J. Heart Fail. doi: 10.1002/ejhf.839 – volume: 24 start-page: 377 issue: 2 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0115 publication-title: J. Nucl. Cardiol. doi: 10.1007/s12350-015-0336-8 – volume: 19 start-page: 357 issue: 3 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0085 article-title: Variability of biomarkers in patients with chronic heart failure and healthy controls[J] publication-title: Eur. J. Heart Fail. doi: 10.1002/ejhf.669 – year: 2019 ident: 10.1016/j.yexmp.2020.104529_bb0100 – volume: 11 start-page: 653 issue: 2 year: 2018 ident: 10.1016/j.yexmp.2020.104529_bb0025 article-title: TF-lncRNA regulation network of glioblastoma reveals specific topological features and prognostic lncRNAs[J] publication-title: Int. J. Clin. Exp. Med. – volume: 33 start-page: 706 issue: 4 year: 2018 ident: 10.1016/j.yexmp.2020.104529_bb0125 article-title: lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer[J] publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.03.006 – volume: 434 start-page: 1 year: 2018 ident: 10.1016/j.yexmp.2020.104529_bb0055 article-title: Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer[J] publication-title: Cancer Lett. doi: 10.1016/j.canlet.2018.06.039 – volume: 54 start-page: 7670 issue: 10 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0130 article-title: LncRNA-N1LR enhances neuroprotection against ischemic stroke probably by inhibiting p53 phosphorylation[J] publication-title: Mol. Neurobiol. doi: 10.1007/s12035-016-0246-z – volume: 12 start-page: 9 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0020 article-title: Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis[J] publication-title: PLoS One – volume: 38 start-page: 2890 issue: 38 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0005 article-title: Associations of serum potassium levels with mortality in chronic heart failure patients[J] publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehx460 – volume: 70 start-page: 61 year: 2018 ident: 10.1016/j.yexmp.2020.104529_bb0045 article-title: Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters[J] publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2018.02.013 – volume: 63 start-page: 3 issue: 4 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0010 article-title: Platelet-derived miR-142-3p induces apoptosis of endothelial cells in hypertension[J] publication-title: Cell. Mol. Biol. doi: 10.14715/cmb/2017.63.4.1 – volume: 16 start-page: 8045 issue: 6 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0070 article-title: Interaction network of coexpressed mRNA, miRNA, and lncRNA activated by TGF-β1 regulates EMT in human pulmonary epithelial cell[J] publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2017.7653 – volume: 3 start-page: 7 issue: 1 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0105 article-title: Global public health burden of heart failure[J] publication-title: Cardiac Fail. Rev. doi: 10.15420/cfr.2016:25:2 – year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0050 article-title: Therapeutic applications of SAMMSON lncRNA inhibition in uveal melanoma – volume: 8 start-page: 464 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0140 article-title: Attenuation of TNF-α-induced inflammatory injury in endothelial cells by ginsenoside Rb1 via inhibiting NF-κB, JNK and p38 signaling pathways[J] publication-title: Front. Pharmacol. doi: 10.3389/fphar.2017.00464 – volume: 102 start-page: 240 year: 2019 ident: 10.1016/j.yexmp.2020.104529_bb0015 article-title: Heart failure Council of Thailand (HFCT) 2019 heart failure guideline: pharmacologic treatment of chronic heart failure-part I[J] publication-title: J. Med. Assoc. Thail. – volume: 7 start-page: 553 issue: 6 year: 2018 ident: 10.1016/j.yexmp.2020.104529_bb0080 article-title: How is cardiac troponin released from injured myocardium?[J] publication-title: Eur. Heart J. Acute Cardiovasc. Care doi: 10.1177/2048872617748553 – volume: 386 start-page: 11 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0110 article-title: LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway[J] publication-title: Toxicology doi: 10.1016/j.tox.2017.05.007 – volume: 120 start-page: 15233 issue: 9 year: 2019 ident: 10.1016/j.yexmp.2020.104529_bb0075 article-title: lncRNA GAS5 acts as a ceRNA for miR-21 in suppressing PDGF-bb-induced proliferation and migration in vascular smooth muscle cells[J] publication-title: J. Cell. Biochem. doi: 10.1002/jcb.28789 – volume: 8 start-page: 81572 issue: 46 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0060 article-title: The role of miRNA and lncRNA in gastric cancer[J] publication-title: Oncotarget doi: 10.18632/oncotarget.19197 – volume: 135 start-page: 1214 issue: 13 year: 2017 ident: 10.1016/j.yexmp.2020.104529_bb0030 article-title: Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012[J] publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.025941 – volume: 391 start-page: 572 issue: 10120 year: 2018 ident: 10.1016/j.yexmp.2020.104529_bb0035 article-title: Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals[J] publication-title: Lancet doi: 10.1016/S0140-6736(17)32520-5 – volume: 68 start-page: 736 issue: 3 year: 2016 ident: 10.1016/j.yexmp.2020.104529_bb0120 article-title: Long noncoding RNA-GAS5: a novel regulator of hypertension-induced vascular remodeling[J] publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.116.07259 – volume: 12 start-page: 11141 issue: 9 year: 2019 ident: 10.1016/j.yexmp.2020.104529_bb0135 article-title: Regulation and mechanisms of lncRNA H19 in COPD[J] publication-title: Int. J. Clin. Exp. Med. – reference: 34602257 - Exp Mol Pathol. 2021 Oct;122:104683 |
SSID | ssj0009012 |
Score | 2.2506585 |
SecondaryResourceType | retracted_publication |
Snippet | This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal).... Chronic heart failure (CHF) is a common disease in clinical practice, and its incidence has been increasing in recent years. Understanding the pathogenesis of... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 104529 |
SubjectTerms | Adult Aged Apoptosis - genetics Cell Line Female Heart Failure - blood Heart Failure - pathology Humans Interleukin-6 - blood Male MicroRNAs - blood Middle Aged Myocardium - metabolism Myocardium - pathology RNA, Long Noncoding - blood Tumor Necrosis Factor-alpha - blood |
Title | RETRACTED: Low-expressed GAS5 injure myocardial cells and progression of chronic heart failure via regulation of miR-223-3P |
URI | https://dx.doi.org/10.1016/j.yexmp.2020.104529 https://www.ncbi.nlm.nih.gov/pubmed/32926880 https://www.proquest.com/docview/2442845215 |
Volume | 117 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEF_Egu1Lae3XqZUt9LFbL8lms-fbcWhPr4pclfq27Fcg4uXkvPMDwb-9M7uJUqg-9Ckk2ZBlZpj5Jfvb3xDyFYJA97wzLOfGMJ7wgmnhUqZlJrQthJYSNwofHIrhCd8_zU-XyKDdC4O0yib3x5wesnVzZaux5tZFVeEeX_gYCHgnA9iToyYo5wVG-ff7R5oH1LuoGJ5whqNb5aHA8br1NxMUrUzDWmcecOY_q9NT6DNUod035HUDH2k_zvAtWfL1Knk5aLu2rZKVg2ax_B25G-8cj_sDSE3b9Of0mvmbQHr1jv7o_8ppVZ8tZp5ObqGaYZScU_yJf0l17WhgbUXFDjotqY0KuhS7X89pqSvkstOrStNZbGXfjJtUYwZAgGVH78nJ7s7xYMiaXgvMpkgq9EXuu9zJhBud9cD4GqCQtaV1SQ73hE-4NbzrUllKY40UDnCGKVyifWZF6rIPZLme1v4Tod3ElBmXpZAojcOtFInTGjzfc6aE4tchaWtjZRshcuyHca5axtmZCo5R6BgVHdMh3x4euog6HM8PF63z1F_hpKBSPP_gl9bVCjyHhte1ny4uFeAgKOWAdvIO-Rhj4GEmWdpLBWTCtf997Tp5hWeRJ7NBluezhf8MaGduNkM4b5IX_b3R8BCPo_Hv0R_YWP8G |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VVKJcEJRXeBqJI1azu7bjcIuilpQmEQqp1Jvl10pbNZsqTaAVf56xvVuEBD1wXdtaa2Y08-368zcAHzAI9MA7QzkzhrKM9akWLqdaFkLbvtBShovC05kYn7IvZ_xsB0btXZhAq2xyf8rpMVs3Tw4aax5cVlW444sfAxHvFAh7OLsHu0Gdindgd3h8Mp791t7tZUk0PGM0LGjFhyLN68ZfL4NuZR6PO3mEmn8tUP8CoLEQHT2Chw2CJMO0ycew4-t92Bu1jdv24f60OS9_Aj_nh4v5cITZ6ROZrH5Qfx15r96Rz8NvnFT1-XbtyfIGC1oIlAsS_uNfEV07EolbSbSDrEpik4guCQ2wN6TUVaCzk--VJuvUzb6Zt6zmFLEALb4-hdOjw8VoTJt2C9TmgVfo-9z3mJMZM7oYoP01oiFrS-syjmPCZ8wa1nO5LKWxRgqHUMP0XaZ9YUXuimfQqVe1fwGkl5myYLIUMqjjMCtF5rRG5w-cKbH-dSFvbaxso0UeWmJcqJZ0dq6iY1RwjEqO6cLH20WXSYrj7umidZ76I6IUFou7F75vXa3Qc8Hwuvar7ZVCKITVHAEP78LzFAO3OynyQS4wGb7839e-g73xYjpRk-PZySt4EEYSbeY1dDbrrX-D4Gdj3jbB_QuWWgAj |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=RETRACTED%3A+Low-expressed+GAS5+injure+myocardial+cells+and+progression+of+chronic+heart+failure+via+regulation+of+miR-223-3P&rft.jtitle=Experimental+and+molecular+pathology&rft.au=Li%2C+Gang&rft.au=Du%2C+Pang&rft.au=Qiang%2C+Xu&rft.au=Jin%2C+Dayong&rft.date=2020-12-01&rft.issn=0014-4800&rft.volume=117&rft.spage=104529&rft_id=info:doi/10.1016%2Fj.yexmp.2020.104529&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_yexmp_2020_104529 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-4800&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-4800&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-4800&client=summon |